🏥
🏥 Health
Glucosamine may speed mild memory disorder's shift to Alzheimer's
Analysis of a large medical records database found that people taking glucosamine — a popular joint supplement — had 25% higher risk of mild cognitive impairment progressing to full dementia. Lab experiments suggest the supplement may intensify abnormal protein modification processes in Alzheimer's brains. Researchers stress that clinical trials are needed to establish whether the link is causal.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!